Table 3.
Correlations among variables (N = 134).
| PDSS-2 total | PDSS-2 motor| | PDSS-2 Night symptom | PDSS-2 Disturbed sleep | |
|---|---|---|---|---|
| Onset age | −0.12 | −0.20* | −0.19* | −0.06 |
| Current age | 0.06 | −0.07 | 0.05 | 0.07 |
| Disease duration | 0.33** | 0.27** | 0.26** | 0.25** |
| MMSE | 0.05 | 0.01 | −0.03 | −0.07 |
| UPDRS total | 0.44** | 0.38** | 0.45** | 0.40** |
| UPDRS Part I | 0.17 | 0.15 | 0.17* | 0.21* |
| UPDRS Part II | 0.47** | 0.43** | 0.47** | 0.42 |
| UPDRS Part III | 0.27** | 0.23** | 0.28** | 0.21* |
| UPDRS Part IV | 0.40** | 0.40** | 0.44** | 0.43** |
| BDI | 0.39** | 0.25** | 0.40** | 0.47** |
| BAI | 0.44** | 0.39** | 0.41** | 0.34** |
| H&Y | 0.38** | 0.25** | 0.22* | 0.25** |
| PDQ-39 | 0.53** | 0.41** | 0.52** | 0.47** |
| PDSS-2 | – | 0.69** | 0.69** | 0.68** |
| LEDD total | 0.41** | 0.31** | 0.37** | 0.38** |
| Dopamine agonist | −0.01 | −0.04 | 0.13 | −0.04 |
PDSS-2, Parkinson Disease Sleep Scale-2; UPDRS, Unified Parkinson Disease Rating Scale; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; H&Y, Hoehn and Yahr scale; PDQ-39, 39-item Parkinson Disease Questionnaire; LEDD, Levodopa Equivalent Daily Dosage.
p < 0.05,
p < 0.01.